undamentalytics Newsletter
Sign in

Bruker Corp income statement

In fiscal 2025, Bruker Corp reported revenue of $3.44bn, up 2.1% on the year before, operating income of $68.2m (a 2.0% margin) and net income of −$8.6m, or −$0.15 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue1,1151,3051,6521,7911,8391,8091,6241,6111,7661,8962,0731,9882,4182,5312,9653,3663,4373,500
Cost of revenue5977018999621,0341,0469158669509961,0771,0481,2081,2251,4511,7171,8591,875
Gross profit5186047538298057637097458169009959401,2101,3061,5131,6501,5781,624
Research and development126141177195191174146148162173188198221236295377395394
Selling, general and administrative254301407440438451392390415445500469561607729894947971
Operating income13715615615614810514618222026230124841343343725368−31
Interest expense867141313131315131614141616486062
Income before tax12915014613812510112817819824528022639441454420722−22
Income tax4853526043422323118648264113116118912940
Net income81959278805710215479180197158277297427113−9−71
Diluted EPS$0.49$0.58$0.55$0.46$0.48$0.33$0.60$0.95$0.49$1.14$1.26$1.02$1.81$1.99$2.90$0.76−$0.15−$0.47
Diluted shares (average)165m166m167m167m169m170m169m162m159m157m157m155m153m149m147m150m152m152m
EBITDA166192209215210165199236283327377329502522552437289200

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: BRKR vs CRLBRKR vs MTDBRKR vs MEDP

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Bruker Corp's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Bruker Corp.